MedPath

Safety Study of Shenmai(a Chinese Medicine Injection) Used in Hospitals in China

Conditions
Shock
Coronary Heart Disease
Registration Number
NCT01612611
Lead Sponsor
China Academy of Chinese Medical Sciences
Brief Summary

The purpose of this study is to make a cohort event monitoring to see whether and how Shenmai injection in hospital results in adverse events or adverse drug reactions.

Detailed Description

Safety surveillance on Chinese Medicine injection is an important problem that needs to be sorted out ,because in mainland China hospitals ,Chinese Medicine Injection are used widely. Population for taking medicine characteristics,the incidence rate of ADR and other uncertain factors influence can not be found now.

A registry study for shenmai injection safety surveillance with 30000 patients will be conducted from Jan.2012 to Dec.2015.

Eligibility criteria Patients who will use shenmai injection in selected hospitals.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30000
Inclusion Criteria
  • all inpatients use Shenmai injection in 30 selected hospitals during their hospital stay
Read More
Exclusion Criteria
  • none
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath